Logo.jpg
Biofrontera reports preliminary revenue for the month of May 2021
June 07, 2021 10:01 ET | Biofrontera AG
Leverkusen, Germany, June 07, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera reports Q1 2021 financial results
May 11, 2021 10:41 ET | Biofrontera AG
Leverkusen, Germany, May 11, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo.jpg
Biofrontera reports preliminary revenue for the month of April 2021
May 06, 2021 07:23 ET | Biofrontera AG
Leverkusen, Germany, May 06, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera AG: First quarter conference call to be held on May 12, 2021
May 03, 2021 09:40 ET | Biofrontera AG
Leverkusen, Germany, May 03, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its ...
Logo.jpg
Biofrontera reports results for the 2020 financial year
April 12, 2021 13:57 ET | Biofrontera AG
Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo.jpg
Biofrontera announces preliminary revenue for Q1 2021
April 08, 2021 10:30 ET | Biofrontera AG
Leverkusen, Germany, April 08, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported...
Logo.jpg
Biofrontera announces conference call to be held on April 13, 2021 to discuss fiscal year 2020 financial results
March 31, 2021 10:12 ET | Biofrontera AG
Leverkusen, Germany, March 31, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
Logo.jpg
Biofrontera submits application for FDA approval of new BF-RhodoLED® XL lamp
March 31, 2021 03:40 ET | Biofrontera AG
Leverkusen, Germany, March 31, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...
Logo.jpg
Biofrontera AG announces the closing of the capital raise with gross proceeds of EUR 24.7 million
February 26, 2021 09:20 ET | Biofrontera AG
Leverkusen, Germany, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (“Biofrontera” or the “Company”), an international biopharmaceutical company,...
Logo.jpg
Biofrontera submits study report of pharmacokinetics study to FDA
February 24, 2021 08:30 ET | Biofrontera AG
Leverkusen, Germany, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces the...